REXULTI brexpiprazole 4 mg film coated tablets blisters Australia - English - Department of Health (Therapeutic Goods Administration)

rexulti brexpiprazole 4 mg film coated tablets blisters

lundbeck australia pty ltd - brexpiprazole, quantity: 4 mg - tablet, film coated - excipient ingredients: magnesium stearate; hyprolose; maize starch; microcrystalline cellulose; lactose monohydrate; titanium dioxide; hypromellose; purified talc - rexulti is indicated in adult patients for the treatment of schizophrenia.

REXULTI brexpiprazole 2 mg film coated tablets blisters Australia - English - Department of Health (Therapeutic Goods Administration)

rexulti brexpiprazole 2 mg film coated tablets blisters

lundbeck australia pty ltd - brexpiprazole, quantity: 2 mg - tablet, film coated - excipient ingredients: maize starch; lactose monohydrate; microcrystalline cellulose; hyprolose; magnesium stearate; titanium dioxide; hypromellose; purified talc; iron oxide yellow; iron oxide black - rexulti is indicated in adult patients for the treatment of schizophrenia.

REXULTI brexpiprazole 3 mg film coated tablets blisters Australia - English - Department of Health (Therapeutic Goods Administration)

rexulti brexpiprazole 3 mg film coated tablets blisters

lundbeck australia pty ltd - brexpiprazole, quantity: 3 mg - tablet, film coated - excipient ingredients: magnesium stearate; lactose monohydrate; microcrystalline cellulose; hyprolose; maize starch; titanium dioxide; hypromellose; purified talc; iron oxide red; iron oxide black - rexulti is indicated in adult patients for the treatment of schizophrenia.

REXULTI brexpiprazole 1 mg film coated tablets blisters Australia - English - Department of Health (Therapeutic Goods Administration)

rexulti brexpiprazole 1 mg film coated tablets blisters

lundbeck australia pty ltd - brexpiprazole, quantity: 1 mg - tablet, film coated - excipient ingredients: magnesium stearate; hyprolose; lactose monohydrate; maize starch; microcrystalline cellulose; titanium dioxide; hypromellose; purified talc; iron oxide yellow - rexulti is indicated in adult patients for the treatment of schizophrenia.

ABILIFY MAINTENA aripiprazole (as monohydrate) 400 mg powder and solvent for prolonged release suspension for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

abilify maintena aripiprazole (as monohydrate) 400 mg powder and solvent for prolonged release suspension for injection vial

lundbeck australia pty ltd - aripiprazole, quantity: 400 mg (equivalent: aripiprazole monohydrate, qty 416.07 mg) - injection, diluent for - excipient ingredients: water for injections - for the acute and maintenance treatment of schizophrenia in adults. for maintenance treatment to prevent the recurrence of manic or mixed episodes of bipolar i disorder in adult patients as monotherapy.

ABILIFY MAINTENA aripiprazole (as monohydrate) 300 mg powder and solvent for prolonged release suspension for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

abilify maintena aripiprazole (as monohydrate) 300 mg powder and solvent for prolonged release suspension for injection vial

lundbeck australia pty ltd - aripiprazole, quantity: 300 mg (equivalent: aripiprazole monohydrate, qty 312.05 mg) - injection, diluent for - excipient ingredients: water for injections - for the acute and maintenance treatment of schizophrenia in adults. for maintenance treatment to prevent the recurrence of manic or mixed episodes of bipolar i disorder in adult patients as monotherapy.

LEXAPRO escitalopram (as oxalate) 20 mg/mL oral solution bottle Australia - English - Department of Health (Therapeutic Goods Administration)

lexapro escitalopram (as oxalate) 20 mg/ml oral solution bottle

lundbeck australia pty ltd - escitalopram oxalate, quantity: 25.551 mg/ml (equivalent: escitalopram, qty 20 mg/ml) - oral liquid, solution - excipient ingredients: sodium hydroxide; ethanol; purified water; propyl gallate; citric acid - treatment of major depression. treatment of social anxiety disorder (social phobia). treatment of generalised anxiety disorder. treatment of obsessive-compulsive disorder.

BRINTELLIX vortioxetine (as hydrobromide) 5 mg film-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

brintellix vortioxetine (as hydrobromide) 5 mg film-coated tablet blister pack

lundbeck australia pty ltd - vortioxetine hydrobromide, quantity: 6.355 mg (equivalent: vortioxetine, qty 5 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; magnesium stearate; hyprolose; sodium starch glycollate type a; mannitol; titanium dioxide; hypromellose; iron oxide red; macrogol 400 - treatment of major depressive disorder in adults including prevention of relapse. vortioxetine is not indicated for paediatric use.

BRINTELLIX vortioxetine (as hydrobromide) 15 mg film-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

brintellix vortioxetine (as hydrobromide) 15 mg film-coated tablet blister pack

lundbeck australia pty ltd - vortioxetine hydrobromide, quantity: 19.065 mg (equivalent: vortioxetine, qty 15 mg) - tablet, film coated - excipient ingredients: magnesium stearate; mannitol; sodium starch glycollate type a; hyprolose; microcrystalline cellulose; titanium dioxide; hypromellose; iron oxide yellow; iron oxide red; macrogol 400 - treatment of major depressive disorder in adults including prevention of relapse. vortioxetine is not indicated for paediatric use.

BRINTELLIX vortioxetine (as hydrobromide) 20 mg film-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

brintellix vortioxetine (as hydrobromide) 20 mg film-coated tablet blister pack

lundbeck australia pty ltd - vortioxetine hydrobromide, quantity: 25.42 mg (equivalent: vortioxetine, qty 20 mg) - tablet, film coated - excipient ingredients: sodium starch glycollate type a; magnesium stearate; hyprolose; microcrystalline cellulose; mannitol; titanium dioxide; hypromellose; iron oxide red; macrogol 400 - treatment of major depressive disorder in adults including prevention of relapse. vortioxetine is not indicated for paediatric use.